RWP
GILD icon

Ridgecrest Wealth Partners’s Gilead Sciences GILD Stock Holding History

Ridgecrest Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581K Buy
4,601
+276
+6% +$36.4K 0.28% 53
2026
Q1 		$603K Buy
4,325
+75
+2% +$10.5K 0.33% 51
2025
Q4 		$522K Sell
4,250
-54
-1% -$6.56K 0.28% 56
2025
Q3 		$478K Hold
4,304
– – 0.22% 66
2025
Q2 		$477K Sell
4,304
-300
-7% -$31.9K 0.25% 63
2025
Q1 		$516K Sell
4,604
-14
-0.3% -$1.45K 0.27% 60
2024
Q4 		$427K Buy
4,618
+12
+0.3% +$1.08K 0.23% 65
2024
Q3 		$386K Buy
4,606
+150
+3% +$11.4K 0.2% 75
2024
Q2 		$306K Hold
4,456
– – 0.18% 81
2024
Q1 		$326K Hold
4,456
– – 0.19% 78
2023
Q4 		$361K Sell
4,456
-637
-13% -$49.6K 0.24% 69
2023
Q3 		$382K Hold
5,093
– – 0.27% 61
2023
Q2 		$393K Buy
5,093
+302
+6% +$24.1K 0.26% 63
2023
Q1 		$398K Hold
4,791
– – 0.28% 59
2022
Q4 		$411K Hold
4,791
– – 0.31% 57
2022
Q3 		$296K Sell
4,791
-440
-8% -$27.7K 0.24% 72
2022
Q2 		$323K Sell
5,231
-250
-5% -$15.5K 0.24% 75
2022
Q1 		$326K Sell
5,481
-1,000
-15% -$63.9K 0.21% 85
2021
Q4 		$471K Sell
6,481
-174
-3% -$12K 0.23% 76
2021
Q3 		$465K Buy
6,655
+100
+2% +$7.03K 0.25% 72
2021
Q2 		$451K Buy
6,555
+300
+5% +$20K 0.28% 67
2021
Q1 		$404K Buy
+6,255
New +$403K 0.39% 55

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ridgecrest Wealth Partners's GILD Position: Q2 2026 in Review

Ridgecrest Wealth Partners increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $36.4K and bringing the position to 4,601 shares worth $581K. The position accounts for 0.28% of the portfolio, ranked #53.

Ridgecrest Wealth Partners first reported a position in GILD in Q1 2021 and has held it in 22 quarters since. The position peaked at $603K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ridgecrest Wealth Partners held 4,601 shares of Gilead Sciences worth $581K as of Q2 2026.
  • Ridgecrest Wealth Partners bought 276 Gilead Sciences shares in Q2 2026, an estimated $36.4K.
  • Gilead Sciences made up 0.28% of Ridgecrest Wealth Partners's portfolio in Q2 2026, its #53 holding.
  • Ridgecrest Wealth Partners first reported a position in Gilead Sciences in Q1 2021 and has held it in 22 quarters since.
  • Ridgecrest Wealth Partners's Gilead Sciences position peaked at $603K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ridgecrest Wealth Partners's 13F filing for Q2 2026, filed 5 Aug 2026.